DOCSLIB.ORG

List of Registred Drugs in Armenia (01.01.2016-31.01.2016)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
List of Registred Drugs in Armenia (01.01.2016-31.01.2016) LIST OF REGISTRED DRUGS IN ARMENIA (01.01.2016-31.01.2016) International nonproprietary name Dose and Registration Term of Legal Status for N Trade name Drug form Manufacturer Country ATC1 code License holder (generic) or active packaging number registration Supply ingredients name Altayvitamini CJSC, Altayvitamini CJSC, 100000IU+100mg, 659325, The Altay 659325, The Altay 15.01.2016 1 Aevit-AV vitamin A, vitamin E capsules blister (10/1x10/, Russia A11JA 13088/1 OTC2 territory, Biysk, 69 territory, Biysk, 69 09.12.2018 30/3x10/) Zavodskaya Str., Zavodskaya Str. Russia Pharmstandard- OTCPharm PJSC, fabomotizole Leksredstva JSC, 10mg, 29.01.2016 123317, Moscow, 2 Afobazol (fabomotizole tablets 305022, Kursk, Russia N05BX04 14729/1 PoM3 blisters (60/3x20/) 30.07.2020 Testovskaya str., 10, dihydrochloride) Agregatnaya 2nd str., Russia 1a/18 'KPE' Zdorovye KPE' Zdorovye amitriptyline 25mg, narodu' LLC, Amitriptylin narodu' LLC, 18.01.2016 3 (amitriptyline tablets in blister (25, Ukraine N06AA09 12869/1 PoM Sevchenko str. 22, hydrochloride Melnikova str., 41, 17.09.2018 hydrochloride) 50/5x10/) 61013, Kharkov, 61002, Kharkov Ukraine Altayvitamini CJSC, folic acid, pyridoxine Altayvitamini CJSC, 5mg+4mg+ 659325, The Altay (pyridoxine 659325, The Altay 15.01.2016 4 Angiovit-AV tablets film-coated 0,006mg, Russia A11BA 13067/1 OTC territory, Biysk, 69 hydrochloride), territory, Biysk, 69 09.12.2018 blisters (60/6x10/) Zavodskaya Str., cyanocobalamin Zavodskaya Str. Russia 1 Accord Healthcare Limited, Sage House,319 Pinner Road, North Harrow, Middlesex, HA1 4HF- batch releaser, Intas Pharmaceuticals Limited, Plot No 5/6/7, Pharmez, Near Village Accord Healthcare Matoda, Sarkhej-Bavla Limited, Sage 100mg, Highway, NH-8A, 13.01.2016 House,319 Pinner 5 Atenolol 100mg Tablets atenolol tablets UK C07AB03 15256 PoM in blister (28/2x14/) Matoda, District- 13.01.2021 Road, North Ahmedabad, 382 210, Harrow, Middlesex, Gujarat, India- bulk HA1 4HF, UK manufacturer, Accord Healthcare Limited, Unit C & D, Homefield Business Park, Homefield Road, Haverhill, CB9 8QP, UK-primary and secondary packager Accord Healthcare Limited, Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF - batch releaser, Intas Pharmaceuticals Limited, Plot No 457 & 458 & 191/218 P, Accord Healthcare Sarkhej-Bavla Limited, Sage 100mg, Highway, Matoda 13.01.2016 House,319 Pinner 6 Atenolol 100mg Tablets atenolol tablets UK C07AB03 15258 PoM in blister (28/2x14/) Village, Sanand, 13.01.2021 Road, North District-Ahmedabad, Harrow, Middlesex, 382 210, Gujarat, India- HA1 4HF, UK bulk manufacturer, Accord Healthcare Limited, Unit C & D, Homefield Business Park, Homefield Road, Haverhill, CB9 8QP, UK- primary and secondary packager 2 Accord Healthcare Limited, Sage House,319 Pinner Road, North Harrow, Middlesex, HA1 4HF- batch releaser, Intas Pharmaceuticals Limited, Plot No 5/6/7, Pharmez, Near Village Accord Healthcare Matoda, Sarkhej-Bavla Limited, Sage 25mg, Highway, NH-8A, 13.01.2016 House,319 Pinner 7 Atenolol 25mg Tablets atenolol tablets UK C07AB03 15255 PoM in blister (28/2x14/) Matoda, District- 13.01.2021 Road, North Ahmedabad, 382 210, Harrow, Middlesex, Gujarat, India- bulk HA1 4HF, UK manufacturer, Accord Healthcare Limited, Unit C & D, Homefield Business Park, Homefield Road, Haverhill, CB9 8QP, UK-primary and secondary packager Accord Healthcare Limited, Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF - batch releaser, Intas Pharmaceuticals Limited, Plot No 457 & 458 & 191/218 P, Accord Healthcare Sarkhej-Bavla Limited, Sage 25mg, Highway, Matoda 13.01.2016 House,319 Pinner 8 Atenolol 25mg Tablets atenolol tablets UK C07AB03 15259 PoM in blister (28/2x14/) Village, Sanand, 13.01.2021 Road, North District-Ahmedabad, Harrow, Middlesex, 382 210, Gujarat, India- HA1 4HF, UK bulk manufacturer, Accord Healthcare Limited, Unit C & D, Homefield Business Park, Homefield Road, Haverhill, CB9 8QP, UK- primary and secondary packager 3 Accord Healthcare Limited, Sage House,319 Pinner Road, North Harrow, Middlesex, HA1 4HF- batch releaser, Intas Pharmaceuticals Limited, Plot No 5/6/7, Pharmez, Near Village Accord Healthcare Matoda, Sarkhej-Bavla Limited, Sage 50mg, Highway, NH-8A, 13.01.2016 House,319 Pinner 9 Atenolol 50mg Tablets atenolol tablets UK C07AB03 15257 PoM in blister (28/2x14/) Matoda, District- 13.01.2021 Road, North Ahmedabad, 382 210, Harrow, Middlesex, Gujarat, India- bulk HA1 4HF, UK manufacturer, Accord Healthcare Limited, Unit C & D, Homefield Business Park, Homefield Road, Haverhill, CB9 8QP, UK-primary and secondary packager Accord Healthcare Limited, Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF - batch releaser, Intas Pharmaceuticals Limited, Plot No 457 & 458 & 191/218 P, Accord Healthcare Sarkhej-Bavla Limited, Sage 50mg, Highway, Matoda 13.01.2016 House,319 Pinner 10 Atenolol 50mg Tablets atenolol tablets UK C07AB03 15260 PoM in blister (28/2x14/) Village, Sanand, 13.01.2021 Road, North District-Ahmedabad, Harrow, Middlesex, 382 210, Gujarat, India- HA1 4HF, UK bulk manufacturer, Accord Healthcare Limited, Unit C & D, Homefield Business Park, Homefield Road, Haverhill, CB9 8QP, UK- primary and secondary packager 4 Accord Healthcare Limited, Sage House,319 Pinner Road, North Harrow, Middlesex, HA1 4HF- batch releaser, Intas Pharmaceuticals Limited, Plot No 5/6/7, Pharmez, Near Village Accord Healthcare Limited, Sage Betahistine Matoda, Sarkhej-Bavla betahistine (betahistine 16mg, Highway, NH-8A, 13.01.2016 House,319 Pinner 11 dihydrochloride 16mg tablets UK N07CA01 15261 PoM dihydrochloride) in blister (84/6x14/) Matoda, District- 13.01.2021 Road, North Tablets Ahmedabad, 382 210, Harrow, Middlesex, Gujarat, India- bulk HA1 4HF, UK manufacturer, Accord Healthcare Limited, Unit C & D, Homefield Business Park, Homefield Road, Haverhill, CB9 8QP, UK-primary and secondary packager 5 Accord Healthcare Limited, Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF - batch releaser, Intas Pharmaceuticals Limited, Plot No 457 & 458 & 191/218 P, Accord Healthcare Limited, Sage Betahistine Sarkhej-Bavla betahistine (betahistine 16mg, Highway, Matoda 13.01.2016 House,319 Pinner 12 dihydrochloride 16mg tablets UK N07CA01 15262 PoM dihydrochloride) in blister (84/6x14/) Village, Sanand, 13.01.2021 Road, North Tablets District-Ahmedabad, Harrow, Middlesex, 382 210, Gujarat, India- HA1 4HF, UK bulk manufacturer, Accord Healthcare Limited, Unit C & D, Homefield Business Park, Homefield Road, Haverhill, CB9 8QP, UK- primary and secondary packager Accord Healthcare Limited, Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF - batch releaser, Intas Pharmaceuticals Limited, Plot No 457 & 458 & 191/218 P, Accord Healthcare Limited, Sage Betahistine Sarkhej-Bavla betahistine (betahistine 8mg, Highway, Matoda 13.01.2016 House,319 Pinner 13 dihydrochloride 8mg tablets UK N07CA01 15263 PoM dihydrochloride) in blister (84/6x14/) Village, Sanand, 13.01.2021 Road, North Tablets District-Ahmedabad, Harrow, Middlesex, 382 210, Gujarat, India- HA1 4HF, UK bulk manufacturer, Accord Healthcare Limited, Unit C & D, Homefield Business Park, Homefield Road, Haverhill, CB9 8QP, UK- primary and secondary packager 6 Accord Healthcare Limited, Sage House,319 Pinner Road, North Harrow, Middlesex, HA1 4HF- batch releaser, Intas Pharmaceuticals Limited, Plot No 5/6/7, Pharmez, Near Village Accord Healthcare Limited, Sage Betahistine Matoda, Sarkhej-Bavla betahistine (betahistine 8mg, Highway, NH-8A, 13.01.2016 House,319 Pinner 14 dihydrochloride 8mg tablets UK N07CA01 15264 PoM dihydrochloride) in blister (84/6x14/) Matoda, District- 13.01.2021 Road, North Tablets Ahmedabad, 382 210, Harrow, Middlesex, Gujarat, India- bulk HA1 4HF, UK manufacturer, Accord Healthcare Limited, Unit C & D, Homefield Business Park, Homefield Road, Haverhill, CB9 8QP, UK-primary and secondary packager Pfizer Manufacturing Pfizer H.C.P. Deutschland GmbH, amlodipine (amlodipine Corporation, 235, 5mg+10mg, Betriebsstatte 22.01.2016 15 Caduet besilate), atorvastatin tablets film-coated Germany C10AA55 15269 PoM East 42nd street in blister (30/3x10/) Freiburg, 22.01.2021 (atorvastatin calcium) New York 10017, Mooswaldallee 1, USA 79090 Frieburg Pfizer Manufacturing Pfizer H.C.P. Deutschland GmbH, amlodipine (amlodipine Corporation, 235, 10mg+10mg, Betriebsstatte 22.01.2016 16 Caduet besilate), atorvastatin tablets film-coated Germany C10AA55 15270 PoM East 42nd street in blister (30/3x10/) Freiburg, 22.01.2021 (atorvastatin calcium) New York 10017, Mooswaldallee 1, USA 79090 Frieburg clomifene (clomifene 50mg, 29.01.2016 17 Clostilbegyt tablets Egis PLC Hungary G03GB02 11103/1 PoM Egis PLC, Hungary citrate) glass container (10) 03.11.2016 7 Pharmstandard- OTCPharm PJSC, butamirate (butamirate tablets modified- 50mg, UfaVITA OJSC, 29.01.2016 123317, Moscow, 18 Codelac Neo Russia R05DB13 14833/1 OTC citrate) release film-coated in blister (10/1x10/) 450077, Ufa, str. 04.09.2020 Testovskaya str., 10, Khudaiberdina 28 Russia Nizhpharm JSC, dexpanthenol, Nizhpharm JSC, 603950, Nizhny chlorhexidine cream for external 52,5mg/g+8mg/g, 603950, Nizhny 22.01.2016 19 Depanthol Russia D08AC52 13860/1 OTC Novgorod, GSP- (chlorhexidine use 30g aluminium tube Novgorod, GSP-459, 18.09.2019 459, Salganskaya st., bigluconate) Salganskaya st., 7 7, Russia J. Uriach & Cia., J. Uriach & Cia., S.A. S.A. Av. Cami Av. Cami Reial, 51- 300mg, 22.01.2016 Reial, 51-57, 08184 20 Disgren triflusal capsules hard 57, 08184 Palau- Spain B01AC18 15267 PoM in blister (30/3x10/) 22.01.2021 Palau-Solita
Load more

Recommended publications
  • The Effect of the Roots of Empathy Program on the Use of Psychotropic Medications Among Youth in Manitoba
    The effect of the Roots of Empathy program on the use of psychotropic medications among youth in Manitoba by Lindsey Dahl A Thesis submitted to the Faculty of Graduate Studies of The University of Manitoba in partial fulfilment of the requirements of the degree of MASTER OF SCIENCE Department of Community Health Sciences, Rady Faculty of Health Sciences, Max Rady College of Medicine University of Manitoba Winnipeg Copyright © 2017 by Lindsey Dahl Abstract Background: Psychotropic medications prescriptions to youth have increased. Roots of Empathy (ROE) is a social and emotional learning program that may influence the use of psychotropic medication. Methods: Administrative data was analyzed in a matched sample of children who received ROE during 2002/03 to 2012/13. Kaplan-Meier survival curves and Cox proportional hazard models were used to estimate the association between ROE and psychotropic medication dispensations. Results: Few significant differences were observed. Children who received ROE in kindergarten to grade 3 had a lower adjusted hazard for an anxiolytic dispensation. Children who received ROE in grade 7 to 8 had a higher hazard for an antipsychotic dispensation. Males who received the program had an increased hazard for an antipsychotic dispensation. Conclusion: There was no consistent differences in the likelihood of being dispensed a psychotropic medication between children who received ROE and children who did not in Manitoba. ii Acknowledgments I would like to first thank my thesis advisor Dr. Randy Fransoo of the Department of Community Health Sciences, Rady Faculty of Health Sciences, Max Rady College of Medicine at the University of Manitoba. Right from our initial meeting, Dr.
    [Show full text]
  • List of Registred Drugs in Armenia (01.03.2017-31.03.2017)
    LIST OF REGISTRED DRUGS IN ARMENIA (01.03.2017-31.03.2017) International nonproprietary name Dose and Registration Term of Legal Status N Trade name Drug form Manufacturer Country ATC1 code License holder (generic) or active packaging number registration for Supply ingredients name Eli Lilly Regional Lilly France S.A.S., Operations GmbH., solution for 100IU/ml, Zone Industrielle, 2 17.03.2017 1 Abasaglar insulin glargine France A10AE04 16535 PoM2 Koelblgasse 8-10, injection 3ml cartridges (5) rue du Colonel Lilly, 17.03.2022 1030, Vienna, 67640 Fegersheim Austria Olainfarm JSC, 5 300mg, Olainfarm JSC, 5 06.03.2017 Rupnicu Str., 2 Adaptol mebicar capsules hard in blister (20/2x10/, Rupnicu Str., Olaine, Latvia N06BX21 16440 PoM 06.03.2022 Olaine, LV-2114, 30/3x10/, 40/4x10/) LV-2114 Latvia Olainfarm JSC, 5 Olainfarm JSC, 5 500mg, 06.03.2017 Rupnicu Str., 3 Adaptol mebicar tablets Rupnicu Str., Olaine, Latvia N06BX21 16441 PoM in blister (20/2x10/) 06.03.2022 Olaine, LV-2114, LV-2114 Latvia 10mg, Pharmstandard- OTCPharm PJSC, fabomotizole in blisters Leksredstva JSC, 27.03.2017 123317, Moscow, 4 Afobazol (fabomotizole tablets (30/1x30/, 60/3x20/, 305022, Kursk, Russia N05BX04 14729/2 PoM 30.07.2020 Testovskaya str., 10, dihydrochloride) 60/2x30/, 90/3x30/, Agregatnaya 2nd str., Russia 120/4x30/) 1a/18 Gedeon Richter 15mg/g, Gedeon Richter PLC, 17.03.2017 PLC, Gyomroi ut 5 Airtal aceclofenac cream 60g aluminium Gyomroi ut 19-21, Hungary M01AB16 16514 OTC3 17.03.2022 19-21, 1103 tube 1103 Budapest Budapest, Hungary 1 Gedeon Richter PLC, Gyomroi ut 19-21, 1103 Budapest - batch releaser, Industrias Gedeon Richter Farmaceuticas powder for oral 100mg, 17.03.2017 PLC, Gyomroi ut 6 Airtal aceclofenac Almirall S.L., Ctra.
    [Show full text]
  • LIST of REGISTRED DRUGS in ARMENIA (Up to 31.12.2017)
    LIST OF REGISTRED DRUGS IN ARMENIA (Up to 31.12.2017) International nonproprietary Registration Term of Legal status for N Trade name name (generic) or Drug form Dose and packaging Manufacturer Country ATC1 code License holder number registration supply active ingredients name Lek Pharmaceuticals pefloxacin Lek Pharmaceuticals 400mg, 10.03.2015 d.d., Verovskova Str. 1 Abaktal (pefloxacin tablets film-coated d.d., Verovskova Str. Slovenia J01MA03 14308 PoM2 in blister (10/1x10/) 10.03.2020 57, 1526 Ljubljana, mesylate dihydrate) 57, 1526 Ljubljana Slovenia Lilly France S.A.S., Eli Lilly Regional 100IU/ml, Zone Industrielle, 2 17.03.2017 Operations GmbH., 2 Abasaglar insulin glargine solution for injection France A10AE04 16535 PoM 3ml cartridges (5) rue du Colonel Lilly, 17.03.2022 Koelblgasse 8-10, 67640 Fegersheim 1030, Vienna, Austria Help S.A ,10 ambroxol Help S.A. Pedini, Valaoritou str., GR 6mg/ml, 09.03.2016 3 Abrobion (ambroxol syrup Ioanninon, Ioannina, Greece R05CB06 15404 OTC3 144 52, 125ml glass bottle 09.03.2021 hydrochloride) 45500 Metamorphosis, Attika, Greece Salutas Pharma GmbH, Otto-von- Guericke-Alle-1, 100mg/5ml, 39179 Barleben-batch Sandoz 30g powder in 75ml glass powder for oral releaser, Allphamed Pharmaceuticals d.d., bottle and measuring 20.10.2015 4 ACC acetylcysteine solution with orange Pharbil Arzneimittel Germany R05CB01 14947 OTC Verovskova Str. 57, spoon 5ml, 60g powder in 20.10.2020 flavour GmbH Hildebrandstr. 1000 Ljubljana, 150ml glass bottle and 12, 37081 Gottingen, Slovenia measuring spoon 5ml Germany-bulk manufacturer, packager 1 Salutas Pharma GmbH, Otto-von- Guericke-Alle-1, 39179 Barleben - Sandoz batch releaser Pharmaceuticals d.d., 100mg, 21.11.2014 5 ACC 100 acetylcysteine tablets effervescent (Hermes Pharma Germany R05CB01 13967 OTC Verovskova Str.
    [Show full text]
  • Фармакология Pharmacology
    МИНИСТЕРСТВО ЗДРАВООХРАНЕНИЯ РЕСПУБЛИКИ БЕЛАРУСЬ БЕЛОРУССКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ КАФЕДРА ФАРМАКОЛОГИИ ФАРМАКОЛОГИЯ PHARMACOLOGY Практикум для специальности «Лечебное дело» 5-е издание, переработанное Минск БГМУ 2020 2 УДК 615(076.5)(075.8)-054.6 ББК 52.81я73 Ф24 Рекомендовано Научно-методическим советом университета в качестве практикума 29.05.2020 г., протокол № 9 А в т о р ы: проф. Н. А. Бизунок, проф. Б. В. Дубовик, доц. Б. А. Волынец, доц. А. В. Волчек Р е ц е н з е н т ы: д-р мед. наук, проф. А. В. Хапалюк; д-р. мед. наук, проф. А. И. Волотовский Фармакология = Pharmacology : практикум для специальности «Лечебное дело» / Ф24 Н. А. Бизунок [и др.]. – 5-е изд., перераб. – Минск : БГМУ, 2020. – 156 с. ISBN 978-985-21-0643-6. Содержит методические рекомендации для подготовки к лабораторным занятиям по фармакологии и задания для самостоятельной работы студентов, обучающихся по специальности 1-79 01 01 «Лечебное дело». Первое издание вышло в 2016 году. Предназначен для студентов 3-го курса медицинского факультета иностранных учащихся, изучающих фармакологию на английском языке. УДК 615(076.5)(075.8)-054.6 ББК 52.81я73 ISBN 978-985-21-0643-6 © УО «Белорусский государственный медицинский университет», 2020 3 CONTENTS INTRODUCTION ............................................................................................................................................................. 4 GENERAL PRESCRIPTION ...........................................................................................................................................
    [Show full text]
  • WO 2019/094700 Al 16 May 2019 (16.05.2019) W 1P O PCT
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2019/094700 Al 16 May 2019 (16.05.2019) W 1P O PCT (51) International Patent Classification: (72) Inventors: SANTOS, Michael; One Kendall Square, C07K 14/435 (2006.01) A01K 67/04 (2006.01) Building 200, Cambridge, Massachusetts 02139 (US). A01K 67/00 (2006.01) C07K 14/00 (2006.01) DELISLE, Scott; One Kendall Square, Building 200, Cam¬ A01K 67/033 (2006.01) bridge, Massachusetts 02139 (US). TWEED-KENT, Ailis; One Kendall Square, Building 200, Cambridge, Massa¬ (21) International Application Number: chusetts 02139 (US). EASTHON, Lindsey; One Kendall PCT/US20 18/059996 Square, Building 200, Cambridge, Massachusetts 02139 (22) International Filing Date: (US). PATTNI, Bhushan S.; 15 Evergreen Circle, Canton, 09 November 2018 (09. 11.2018) Massachusetts 02021 (US). (25) Filing Language: English (74) Agent: WARD, Donna T. et al; DT Ward, P.C., 142A Main Street, Groton, Massachusetts 01450 (US). (26) Publication Language: English (81) Designated States (unless otherwise indicated, for every (30) Priority Data: kind of national protection available): AE, AG, AL, AM, 62/584,153 10 November 2017 (10. 11.2017) US AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, 62/659,213 18 April 2018 (18.04.2018) US CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, 62/659,209 18 April 2018 (18.04.2018) US DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, 62/680,386 04 June 2018 (04.06.2018) US HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, 62/680,371 04 June 2018 (04.06.2018) US KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, (71) Applicant: COCOON BIOTECH INC.
    [Show full text]
  • 17Th European Society for Biomedical Research on Alcoholism Congress 21-24 September 2019, Lille – Invited Talks and Symposia Abstracts
    Directeur de la rédaction Pr François Paille Rédacteur en chef Pr Amine Benyamina Rédacteurs associés Dr Philippe Batel Dr Ivan Berlin Dr Laurent Karila Pr Michel Lejoyeux Pr Mickaël Naassila Rédactrice Sciences humaines Pr Myriam Tsikounas Rédactrice Sciences psychologiques Pr Isabelle Varescon-Pousson Comité de rédaction Pr Georges Brousse Pr Olivier Cottencin Dr Michel Craplet Pr Jean-Bernard Daeppen Dr Jean-Michel Delile Pr Maurice Dematteis Dr Claudine Gillet th Dr Geneviève Lafaye 17 European Society for Biomedical Research Pr Michel Reynaud Dr Alain Rigaud Dr Marc Valleur on Alcoholism Congress Directeur de la publication Pr Mickael Naassila 21-24 September 2019, Lille Comité scientifique Pr Jean Adès Pr Thomas F. Babor Pr Jean-Louis Balmès Pr Maurice Bazot Dr Mats Berglund Pr Jacques Besson Pr Jean-Pierre Blayac Pr Jonathan D. Chick Mme Marie Choquet Pr Philippe de Witte Pr Michel Escande Pr Claude Got Dr Antoni Gual Pr Momar Gueye Pr Roger Henrion Pr Denise Kandel Pr Michel Le Moal Pr Karl Mann Mme Véronique Nahoum-Grappe Dr José Maria Neves Cardoso Pr Philippe-Jean Parquet Pr Jean-Louis Pedinielli Pr Falvio Poldrugo Pr Bernard Roques Pr John A. Talbott Pr Jean-Luc Vénisse Pr Lars von Knorring Pr Jacques Weill Pr Jean-Jacques Yvorel ISSN 2554-4853 Trimestriel Société Française PRINCEPS Éditions SEPTEMBRE-DÉCEMBRE 2019 - Tome 41, n° 3-4 d’Alcoologie !BSTRACTS CONGRÈS Pr Mickael Naassila* * President 17th ESBRA Meeting 17th European Society for Biomedical Research on Alcoholism congress 21-24 September 2019, Lille – Invited talks and Symposia abstracts Invited talks forward, such as combining training with neurostimulation.
    [Show full text]
  • Bi-Phasic Dose Response in the Preclinical and Clinical Developments of Sigma-1 Receptor Ligands for the Treatment of Neurodegenerative Disorders Tangui Maurice
    Bi-phasic dose response in the preclinical and clinical developments of sigma-1 receptor ligands for the treatment of neurodegenerative disorders Tangui Maurice To cite this version: Tangui Maurice. Bi-phasic dose response in the preclinical and clinical developments of sigma-1 receptor ligands for the treatment of neurodegenerative disorders. Expert Opinion on Drug Discovery, Informa Healthcare, 2020, 10.1080/17460441.2021.1838483. hal-03020731 HAL Id: hal-03020731 https://hal.archives-ouvertes.fr/hal-03020731 Submitted on 24 Nov 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Bi-phasic dose response in the preclinical and clinical developments of sigma-1 receptor ligands for the treatment of neurodegenerative disorders Tangui MAURICE MMDN, Univ Montpellier, EPHE, INSERM, UMR_S1198, Montpellier, France Correspondance: Dr T. Maurice, MMDN, INSERM UMR_S1198, Université de Montpellier, CC105, place EuGène Bataillon, 34095 Montpellier cedex 5, France. Tel.: +33/0 4 67 14 32 91. E-mail: [email protected] Abstract Introduction: The sigma-1 receptor (S1R) is attracting much attention as a target for disease- modifying therapies in neurodegenerative diseases. It is a highly conserved protein, present in plasma and endoplasmic reticulum (ER) membranes and enriched in mitochondria-associated ER membranes (MAMs).
    [Show full text]
  • Ms O Khorochilova V Euro Rep Ltd
    Case No: 3324680/2017 EMPLOYMENT TRIBUNALS Claimant Respondent Ms O Khorochilova v Euro Rep Ltd OPEN PRELIMINARY HEARING Heard at: Watford On: 1 March 2018 Before: Employment Judge Wyeth Appearances: For the Claimant: Mr P Curry, Friend. For the Respondent: Mr A Mellis, Counsel. JUDGMENT having been sent to the parties on 14 March 2018 and reasons having been requested in accordance with Rule 62(3) of the Rules of Procedure 2013, the following reasons are provided: REASONS The issues 1. Following a preliminary hearing before Employment Judge Smail on 28 July 2017 this matter was listed for a further open preliminary hearing to determine two issues: “(a) whether the claimant has pleaded a claim of disability discrimination which has reasonable prospects of success; (b) whether the claimant was a disabled person at all relevant times; the claimant relies on Mixed Personality Disorder”. 2. It was agreed at the outset of the hearing that the sensible way forward was to determine the second issue first because the claimant would need to establish that she was a disabled person before she could proceed with any disability discrimination claim regardless of potential prospects of success. 3. The claimant’s own case, as advanced before me today, was that before her dismissal there were no irregularities in relation to her situation specifically with regard to depression and anxiety. The claimant was not seeking to advance that she was suffering an impairment of depression and/or anxiety prior to her dismissal from employment by the respondent. The claimant accepts that she suffered the onset of depression and anxiety 1 Case No: 3324680/2017 post her dismissal.
    [Show full text]
  • WO 2017/120012 Al 13 July 20 17 (13.07.2017) W P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2017/120012 Al 13 July 20 17 (13.07.2017) W P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 31/185 (2006.01) A61K 31/336 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, PCT/US20 16/067024 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, 15 December 2016 (15. 12.2016) KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, (25) Filing Language: English NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, (26) Publication Language: English RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, (30) Priority Data: ZA, ZM, ZW. 62/275,182 5 January 2016 (05.01 .2016) US (84) Designated States (unless otherwise indicated, for every (71) Applicant: THE REGENTS OF THE UNIVERSITY kind of regional protection available): ARIPO (BW, GH, OF CALIFORNIA [US/US]; 1111 Franklin Street, 12th GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, Floor, Oakland, California 94607-5200 (US).
    [Show full text]
  • Involvement of Chaperone Sigma1r in the Anxiolytic Effect of Fabomotizole
    International Journal of Molecular Sciences Article Involvement of Chaperone Sigma1R in the Anxiolytic Effect of Fabomotizole Mikhail V. Voronin * , Yulia V. Vakhitova * , Inna P. Tsypysheva , Dmitry O. Tsypyshev , Inna V. Rybina, Rustam D. Kurbanov , Elena V. Abramova and Sergei B. Seredenin * Department of Pharmacogenetics, Federal State Budgetary Institution “Research Zakusov Institute of Pharmacology”, Baltiyskaya Street 8, 125315 Moscow, Russia; [email protected] (I.P.T.); [email protected] (D.O.T.); [email protected] (I.V.R.); [email protected] (R.D.K.); [email protected] (E.V.A.) * Correspondence: [email protected] (M.V.V.); [email protected] (Y.V.V.); [email protected] (S.B.S.); Tel.: +7-(499)1511881 (S.B.S.) Abstract: Sigma-1 receptor (chaperone Sigma1R) is an intracellular protein with chaperone functions, which is expressed in various organs, including the brain. Sigma1R participates in the regulation of physiological mechanisms of anxiety (Su, T. P. et al., 2016) and reactions to emotional stress (Hayashi, T., 2015). In 2006, fabomotizole (ethoxy-2-[2-(morpholino)-ethylthio]benzimidazole dihydrochloride) was registered in Russia as an anxiolytic (Seredenin S. and Voronin M., 2009). The molecular targets of fabomotizole are Sigma1R, NRH: quinone reductase 2 (NQO2), and monoamine oxidase A (MAO- A) (Seredenin S. and Voronin M., 2009). The current study aimed to clarify the dependence of fabomotizole anxiolytic action on its interaction with Sigma1R and perform a docking analysis of fabomotizole interaction with Sigma1R. An elevated plus maze (EPM) test revealed that the Citation: Voronin, M.V.; Vakhitova, anxiolytic-like effect of fabomotizole (2.5 mg/kg i.p.) administered to male BALB/c mice 30 min Y.V.; Tsypysheva, I.P.; Tsypyshev, prior EPM exposition was blocked by Sigma1R antagonists BD-1047 (1.0 mg/kg i.p.) and NE-100 D.O.; Rybina, I.V.; Kurbanov, R.D.; Abramova, E.V.; Seredenin, S.B.
    [Show full text]
  • Lääkeaineiden Yleisnimet (INN-Nimet) 31.12.2019
    Lääkealan turvallisuus- ja kehittämiskeskus Säkerhets- och utvecklingscentret för läkemedelsområdet Finnish Medicines Agency Lääkeaineiden yleisnimet (INN-nimet) 31.12.
    [Show full text]
  • PSYCHIATRIA DANUBINA 2019 • Supplement 4 • Volume 31
    PSYCHIATRIA DANUBINA Psychiatria Danubina (ISSN 0353- 5053) is published quarterly by CONTENTS Medicinska naklada, Cankarova 13, 10000 Zagreb, Croatia; Pro Mente International Congress d.o.o., 10000 Zagreb, Croatia. The cost of a yearly subscription MULTIDISCIPLINARY ASPECTS OF PERSONALIZED to the journal is € 50.00 for institu- tions, € 40.00 for individual sub- APPROACH TO MENTAL HEALTH PROBLEMS scribers and € 30.00 for students - the Moscow, Russia, 27-28th September 2019 prices are without postage (Payments in other currencies will be accepted on the basis of the official currency Boris Tsygankov: WELCOME......................................................................................645 exchange rates). Advertising enquiries, Zhanna Albitskaya: PREDICTORS FORMATION DISABLING MENTAL correspondence and copy requests should be addressed to DISORDERS IN CHILDREN.................................................................................646 Prof. Miro Jakovljeviü, Natalia Aleksandrova & Elena Shkityr: ADDICTIVE BEHAVIOR Psychiatric University Clinic, OF MINORS AS A RISK FACTOR OF SUICIDE ................................................647 KBC Zagreb, Kišpatiüeva 12, HR-10000 Zagreb, Croatia Galina Alekseeva, Elena Pervichko & Nikolay Kibrik: (tel: +385 1 23-88-394; CHARACTERISTIC FEATURES OF SEXUAL IDENTITY tel/fax: +385 1 23-88-329). IN MEN AND WOMEN WITH GENDER DYSPHORIA E-mail: [email protected] IN SCHIZOTYPAL DISORDER............................................................................648 All advertising material
    [Show full text]